Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study

• Main Authors: Cortés-Algara Alfredo (Author), Cárdenas-Rodríguez Noemí (Author), Reyes-Long Samuel (Author), Ortega-Cuellar Daniel (Author), Ruz-Barros Rodrigo (Author), Mondragón-Terán Paul (Author), Escamilla-Tilch Mónica (Author), Correa-Basurto José (Author), Lara-Padilla Eleazar (Author), Alfaro-Rodríguez Alfonso (Author), Cortes-Altamirano José Luis (Author), Bandala Cindy (Author)
• Format: Book
• Published: MDPI AG, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The disease caused by SARS-CoV-2 is still considered a global pandemic. Transdermal patches (TP) with immunoregulators such as estrogen and progesterone compounds could be a feasible option to treat COVID-19 because of their accessibility and relative safety. The objective of the current study was t...